Search

Displaying results 4581 - 4590 of 5383 in total
  1. Drug

    Volociximab

    go.drugbank.com/drugs/DB06647
    Investigational

  2. Drug

    Naproxcinod

    go.drugbank.com/drugs/DB06682
    Investigational

  3. Drug

    Antithrombin Alfa

    go.drugbank.com/drugs/DB11166
    Approved

    Antithrombin Alfa is a recombinant antithrombin , an anticoagulant, that is used for the prevention of thromboembolic events in patients that have hereditary deficiency of antithrombin in high risk situations.

  4. Drug

    Glufosfamide

    go.drugbank.com/drugs/DB06177
    Investigational

  5. Drug

    Darinaparsin

    go.drugbank.com/drugs/DB06179
    Investigational

  6. Drug

    Ultevursen

    go.drugbank.com/drugs/DB17835
    Investigational

    It was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa.

  7. Drug

    Collagen-polyvinylpyrrolidone

    go.drugbank.com/drugs/DB16525
    Investigational

    It is characterized by antifibrotic, fibrolytic, and immunomodulatory properties[A227733].

  8. Drug

    Alfacalcidol

    go.drugbank.com/drugs/DB01436
    ApprovedInvestigationalNutraceutical

    Alfacaldisol is activated by the enzyme 25-hydroxylase in the liver to mediate its effects in the body, or most importantly, the kidneys and bones.

  9. Drug

    Encorafenib

    go.drugbank.com/drugs/DB11718
    ApprovedInvestigational

    approved encorafenib and [binimetinib] (BRAFTOVI and MEKTOVI, Array BioPharma Inc.) in combination for patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by

  10. Drug

    AICA ribonucleotide

    go.drugbank.com/drugs/DB01700
    Investigational

    of tissues by changing the physical composition of muscle. … The drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery and is currently of interest as a potential treatment for diabetes by increasing the metabolic activity